Healthy signs at public and private companies
Reflecting the relative health of the spatial biology field, this year’s A-List shows that the revenues for the top five public companies in spatial biology have climbed a healthy 21% year over year, to just under $3.116 billion between January 2023 and June of this year, from about $2.612 billion between January 2022 and June 2023. Total capital raised by the top five private companies climbed 15.5% year over year, to more than $591 million this year from more than $511.5 million in 2023.
This A-List actually encompasses two lists—one for public companies, and one for private companies. (The online version of this A-List actually also encompasses a third list—one for “up and coming” companies of note.)
